Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S125282-10mg | 10mg | In stock | $19.90 | |
S125282-50mg | 50mg | In stock | $66.90 | |
S125282-250mg | 250mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $232.90 | |
S125282-1g | 1g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $659.90 | |
S125282-5g | 5g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,289.90 |
Synonyms | Safinamide|133865-89-1|(S)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide|(2S)-2-[[4-[(3-Fluorophenyl)methoxy]phenyl]methylamino]propanamide|Xadago|EMD 1195686|EMD-1195686|UNII-90ENL74SIG|90ENL74SIG|Fce-26743|2-(4-(3-Fluorobenzyloxy)benzylamino)propi |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | Safinamide is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, Safinamide is voltage-dependent sodium and calcium channel blocker. Safinamide appears to bind to th |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Monoamine oxidase B inhibitor |
Note | 10mg卖完停产,不再备货 |
Product Description | Safinamide (EMD 1195686; FCE 26743) selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold selectivity against MAO-A. |
ALogP | 2.2 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide |
---|---|
INCHI | InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1 |
InChi Key | NEMGRZFTLSKBAP-LBPRGKRZSA-N |
Canonical SMILES | CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F |
Isomeric SMILES | C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F |
PubChem CID | 131682 |
Molecular Weight | 302.34 |
PubChem CID | 131682 |
---|---|
CAS Registry No. | 133865-89-1 |
ChEMBL Ligand | CHEMBL396778 |
Wikipedia | Safinamide |
DrugCentral Ligand | 4921 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E1529132 | Certificate of Analysis | Jan 11, 2023 | S125282 |
Solubility | DMSO |
---|---|
Sensitivity | heat sensitive |
Melt Point(°C) | 212°C |
Pictogram(s) | GHS06, GHS09, GHS05 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed H318:Causes serious eye damage H400:Very toxic to aquatic life |
Precautionary Statements | P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P391:Collect spillage. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P317:Get emergency medical help. |
1. Caccia C, Maj R, Calabresi M, Maestroni S, Faravelli L, Curatolo L, Salvati P, Fariello RG. (2006) Safinamide: from molecular targets to a new anti-Parkinson drug.. Neurology, 67 (7 Suppl 2): (S18-23). [PMID:17030736] |
2. Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A. (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs.. J Med Chem, 50 (23): (5848-52). [PMID:17915852] |